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Abstract: The aggregation of proteins into insoluble amyloid fibrils coincides with the 
onset of numerous diseases. An array of techniques is available to study the different stages 
of the amyloid aggregation process. Recently, emphasis has been placed upon the analysis 
of oligomeric amyloid species, which have been hypothesized to play a key role in disease 
progression. This paper reviews techniques utilized to study aggregation of the amyloid-β 
protein  (Aβ)  associated  with  Alzheimer’s  disease.  In  particular,  the  review  focuses  on 
techniques that provide information about the size or quantity of oligomeric Aβ species 
formed  during  the  early  stages  of  aggregation,  including  native-PAGE,  SDS-PAGE,  
Western  blotting,  capillary  electrophoresis,  mass  spectrometry,  fluorescence  correlation 
spectroscopy, light scattering, size exclusion chromatography, centrifugation, enzyme-linked 
immunosorbent assay, and dot blotting. 
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1. Introduction 
Protein aggregation leads to the formation of insoluble fibrous aggregates, termed amyloids, which 
are commonly associated with disease. However, understanding of the mechanism by which proteins 
aggregate has remained elusive. Although larger aggregates, including fibrils, remain important for 
clinical determination [1,2], small oligomeric aggregates are of interest due to their potentially toxic 
nature and hypothesized role in disease progression. However, the study  of oligomers is complex  
due to the fact that these early aggregates  are  highly unstable, present at low concentrations,  and 
difficult to isolate. 
Among  the  diseases  to  which  amyloids  contribute  are  Alzheimer’s  disease  (AD),  Parkinson’s 
disease, prion diseases, Type II diabetes mellitus, Huntington’s disease, as well as many others [3]. 
The clinical presentation of each amyloid disease is very different, yet the presence of amyloid fibrils 
is a common characteristic of each disease. These amyloid fibrils exhibit a cross β-sheet structure in 
which the β-strands are oriented perpendicular to and hydrogen bonding is oriented parallel to the long 
axis of the fibril [4–9]. In addition, it has been shown that the amyloidogenic proteins amyloid-β (Aβ), 
α-synuclein, huntingtin, prion, and islet amyloid polypeptide (IAPP) form structurally similar soluble 
oligomeric species, which share an epitope recognized by  oligomer-specific  antibodies [10,11].  The 
commonalities shared by each amyloid disease protein suggest that studying the aggregation of one 
amyloid protein could provide insight into the general aggregation mechanism of other amyloid proteins. 
AD is the most common cause of dementia and the most prevalent neurodegenerative disorder [12,13]. 
The neurodegenerative effects of AD are hypothesized to arise from Aβ, a partially folded protein that 
aggregates during the disease process. Aβ was first identified by Masters et al. as the aggregated 
protein [14] deposited within plaque cores found in AD brain. In its monomeric form, this protein may 
be harmless [15]. However, Aβ monomer can self-assemble via a nucleation-dependent pathway into 
Aβ oligomers, larger Aβ aggregation intermediates, and eventually the fibrillar aggregates that deposit 
in the brain (Figure 1) [5,16–18]. Steps within the Aβ aggregation pathway are reversible, such that 
deposited fibrils could give rise to soluble oligomers and intermediates. Soluble aggregate species that 
appear between monomer and insoluble fibrils have been termed within the literature as oligomers [19], 
micelles [20], amyloid-derived diffusible ligands (ADDLs) [21,22], βamy balls [23], amylospheroids 
(ASPDs)  [24],  and  protofibrils  [25,26],  and  the  aggregate  sizes  associated  with  these  definitions 
overlap in range. Smaller species are most commonly referred to as oligomers, including both low 
molecular weight and high molecular weight species, while larger intermediates are often referred to as 
protofibrils. Controversy exists concerning the exact size of the nucleus formed within the rate-limiting 
step of the aggregation pathway; however, most reports speculate that the nucleus is oligomeric in 
nature [27–29]. In addition to oligomers formed along the aggregation pathway, off pathway oligomers 
and higher order assemblies, which fail to give rise to an organized fibril structure, have also been 
identified [29,30]. 
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progression and severity. Therefore, it is important to gain a better understanding of the formation of 
smaller Aβ species in order to halt the progression of AD. The ability to identify and quantify the size 
of these Aβ oligomeric species without disrupting their structure is of utmost importance in order to 
effectively study the aggregation process and develop treatments that target these pivotal oligomerization 
events. Accordingly, this review focuses primarily upon techniques that have been employed in the  
study of in vitro aggregation of Aβ. Currently, a commonly used technique for the quantification of Aβ 
oligomer sizes within in vitro studies is polyacrylamide gel electrophoresis (PAGE). Other techniques 
that have been applied for determining the size of Aβ oligomers include Western blotting, capillary 
electrophoresis, mass spectrometry, fluorescence correlation spectroscopy, light scattering, centrifugation, 
and  size  exclusion  chromatography  (SEC).  Furthermore,  techniques  including  enzyme-linked 
immunosorbent assay (ELISA) and dot blot have been applied to identify Aβ oligomers, but give no 
size estimates. In the subsequent sections, we will discuss the application of each of these techniques 
to study Aβ oligomers. 
2. Electrophoretic Techniques for the Quantification of Aβ Oligomer Sizes 
2.1. SDS- and Native-PAGE 
SDS-PAGE is the most common electrophoretic technique used for Aβ oligomer size determination 
in protein aggregation studies. Furthermore, a review by Bitan et al. cited SDS-PAGE as the most 
common method used to characterize toxic protein oligomers [44]. SDS-PAGE relies on the ability of 
SDS, a negatively charged detergent, to bind to the protein of interest. This binding typically results in 
the removal of secondary, tertiary, and quaternary structures from the protein. The SDS groups attach 
to the protein in a nearly uniform manner that gives the protein a charge approximately proportional to 
its length, thereby allowing for size based separations. Following the gel electrophoretic separation of 
proteins, the gel may be stained with a dye such as Coomassie Brilliant Blue or silver stain. 
Many research groups have utilized SDS-PAGE, as a standalone technique, to study the evolution 
of Aβ species over time. A study by Ying et al. used SDS-PAGE to separate oligomers formed by 
100 µM Aβ1-42 incubated at 4 °C for 1 day [45]. SDS-PAGE revealed bands for monomer (4.5 kDa), 
trimer/tetramer (16.5 kDa), and higher molecular weight intermediates (>83 kDa) that appeared as a 
smear. The oligomer pattern of freshly dissolved Aβ peptides and Aβ peptides after a 7 day incubation 
have been observed by Satoh et al. [46]. Both Aβ1-40 and Aβ1-42 peptides incubated for 7 days as well 
as the freshly dissolved Aβ1-42 peptide exhibited a range of species from 5–20 kDa (Figure 2). However, 
the resolution of these species was low due to gel smearing. Smearing in these gels may be due to  
the resolution limitations of the gel or could be due to continuous associations and disassociations of  
the  aggregating  species  occurring  during  the  electrophoresis  analysis.  Whatever  the  cause,  gel  
smearing interferes with the ability to identify a particular species and is often overcome by combining 
SDS-PAGE with another technique (see Sections 2.2 and 2.3). Int. J. Mol. Sci. 2012, 13  3042 
 
Figure  2. Tricine-SDS-PAGE analysis of the aggregation states of Aβ peptides freshly 
dissolved  or  incubated  for  7  days.  Aβ1-42  exhibits  bands  at  5–20  kDa  in  both  freshly 
prepared  samples  and  samples  incubated  for  7  days.  Aβ1-40  incubated  for  7  days  also 
exhibits a smear at higher molecular weights, which is absent in freshly prepared samples. 
Reprinted from [46], with permission from Elsevier. 
 
Although the anionic micelles formed by SDS enhance separation, they can also induce non-native 
behavior. SDS has been reported to accelerate the generation of Aβ fibrils. Sureshbabu et al. have 
shown that Aβ1-42 freshly prepared in phosphate buffered saline exhibits monomer, trimer (~13.5 kDa), 
and tetramer (~18 kDa) bands when analyzed via Western blotting [47]. The addition of 1.5 mM SDS 
to the sample produced bands at 20 and 50 kDa. They proposed that the addition of 1.5 mM SDS 
causes Aβ1-42 to develop a partial helical structure whose hydrophobicity induces aggregation. One way 
to counter this phenomenon is to add urea to the sample to further denature the peptide and prevent 
aggregation. However, the migration behavior of Aβ peptides in urea SDS-PAGE is inconsistent. A 
study by Kawooya et al. showed that the Aβ peptide exhibits an unusual electrophoretic mobility in urea 
SDS-PAGE that is proportional to the sum of the hydrophobicity consensus of the peptide rather than the 
number of amino acids in the peptide [31]. Therefore, under these conditions SDS-PAGE may provide 
information about the hydrophobicity of the peptide and not the size. The drawbacks of SDS-PAGE 
may be overcome by using native-PAGE to separate various Aβ sizes under conditions that allow the 
protein to remain in a native state. 
Native or “non-denaturing” gel electrophoresis is similar to SDS gel electrophoresis, except this 
technique is run in the absence of SDS. With native-PAGE, protein mobility depends on both charge 
and hydrodynamic size. This differs from SDS-PAGE, where protein mobility depends primarily on 
molecular  mass.  Since  Aβ  aggregation  is  a  process  that  involves  changes  in  protein  conformation, 
native-PAGE is often a suitable technique to detect various sizes of Aβ species. A study by Iurascu et al. 
used both SDS-PAGE and Tris-tricine PAGE to analyze the species formed by a solution of Aβ1-40 
solubilized in fibril growth buffer at pH 7.5 for 5 days at 37 °C [48]. They found that SDS-PAGE was 
able to detect Aβ1-40 monomeric species, Aβ1-40 oligomeric species of 20 kDa, and high molecular Int. J. Mol. Sci. 2012, 13  3043 
 
weight aggregates >98 kDa. In contrast, Tris-tricine PAGE was able to separate these Aβ oligomers 
into monomer, dimer, trimer, and high molecular weight Aβ sizes. Klug et al. have also compared 
native and SDS-PAGE analyses of Aβ aggregation [49]. They observed the presence of oligomers and 
high molecular weight species using native-PAGE with the majority of Aβ species observed in the 
high molecular mass region of the gel. In contrast, SDS-PAGE showed lower molecular weight species 
(<14 kDa) with only trace amounts of high molecular weight species (>50 kDa), suggesting that the 
removal  of  higher  order  protein  structures  by  SDS  may  destabilize  aggregates.  The  differences 
between native-PAGE and SDS-PAGE highlight the importance of examining more than one method 
for studies of the various Aβ aggregate sizes formed throughout the aggregation process. 
2.2. SDS-PAGE in Combination with Western Blotting 
Western  blotting  is  a  popular  technique  used  to  further  process  samples  after  electrophoretic 
separation. This technique provides a more sensitive detection of separated proteins. This detection is 
achieved by transferring separated proteins to a membrane where they are detected using antibodies 
specific to the protein of interest. Antibodies may be either monoclonal or polyclonal and are typically 
specific for a particular part of the Aβ sequence or a particular amyloid conformation. Some common 
antibodies  and  their  recognition  motifs  are  listed  in  Table  1.  Selecting  the  proper  antibody  is  an 
important consideration in order to achieve detection of the desired Aβ species or aggregation state. 
Table 1. Antibodies used for amyloid-β protein (Aβ) detection in Western blot analysis 
and their respective Aβ recognition motifs. 
Antibody  Recognition Motif  Monoclonal/Polyclonal  References 
6E10  Aβ1-17  Monoclonal  [50–53] 
Ab9  Aβ1-16  Monoclonal  [54] 
6C6  Aβ1-16  Monoclonal  [50] 
4G8  Aβ17-24  Monoclonal  [50] 
2G3  Aβ31-40  Monoclonal  [55] 
BA-27  Aβ1-40, C-terminal  Monoclonal  [56] 
BC-05  Aβ1-42, C-terminal  Monoclonal  [56] 
A8  amyloid oligomers  Monoclonal  [45] 
A11  amyloid oligomers  Monoclonal  [10,57,58] 
NU-4  amyloid oligomers  Monoclonal  [59] 
OC  amyloid fibrils  Polycolonal  [60] 
Numerous  research  groups  have  utilized  Western  blot  analyses  of  SDS-PAGE  separations  to 
characterize  SDS-stable  Aβ  assemblies  [21,39,45,50–53,55].  Ryan  et  al.  analyzed  Aβ1-42  oligomer 
preps via silver staining and immunoblot with the 6E10 antibody [52]. The band intensity for monomer, 
trimer, and tetramer bands was similar for both methods. However, 46 and 56 kDa intermediate sized 
oligomers  were  more  apparent  in  the  immunoblot  analysis.  Moore  et  al.  have  also  found  that 
immunoblot stains of Aβ1-42 oligomers yield better results than silver stains [54]. 
SDS-PAGE with Western blotting has also been used to monitor the formation of Aβ oligomers  
in cell culture. A study by Walsh et al. employed SDS-PAGE followed by Western blotting to probe 
the formation of Aβ oligomers in APP-expressing Chinese hamster ovary (CHO) cells [50]. Bands Int. J. Mol. Sci. 2012, 13  3044 
 
corresponding to ~4, 6, 8, and 12 kDa were obtained using the monoclonal antibody 6E10. However, it 
was necessary to concentrate the Aβ protein via immunoprecipitation with an Aβ-specific antibody 
prior to performing electrophoretic separation. 
Within in vitro studies of Aβ aggregation, Aβ is typically solubilized in 1,1,1,3,3,3-hexafluoro-2-
propanol (HFIP) to break up any residual aggregates that may be present in solution [61]. The HFIP is 
allowed to evaporate, and the peptide film is either resuspended in an organic solvent such as dimethyl 
sulfoxide  (DMSO)  and  diluted  into  culture  media  or  resuspended  in  a  buffer  solution  such  as 
phosphate buffered saline (PBS). Following incubation, samples are analyzed to detect the presence of 
oligomeric species. Dahlgren et al. utilized such an Aβ1-40 oligomer preparation employing DMSO and 
F12 culture media with incubation at 4 °C for 24 h [53]. Western blot analysis using the 6E10 antibody 
showed bands corresponding to monomer and tetramer. Similar results were obtained by Stine et al. 
using the same sample preparation [51]. Walsh et al. utilized an Aβ1-40 oligomer preparation in PBS  
(pH 7.4) at 37 °C [55]. After 5 days, Western blot analysis using the antibody 2G3 showed bands 
corresponding  to  monomer,  dimer,  and  tetramer.  However,  intermediate  sizes  of  oligomeric  species  
>20 kDa were not obtained. 
In addition to Aβ1-40, oligomeric Aβ1-42 species formed in vitro have been well characterized using 
Western  blot  analyses.  Stine  et  al.  studied  the  formation  of  Aβ1-42  oligomers  using  two  different 
antibodies, 6E10 and 4G8 [51]. At 0 h, bands for monomer, trimer, and a faint tetramer band were 
obtained. After 24 h, these bands were more intense and a smear corresponding to oligomeric species 
ranging from 30 to 70 kDa was present. Furthermore, no differences in the band patterns obtained using 
the 6E10 and 4G8 antibodies were observed. Dahlgren et al. obtained comparable 24 h incubation results 
using the same oligomer preparation as Stine et al. [53]. In addition, similar 0 and 24 h results were 
obtained  by  Ryan  et  al.  using  a  monomer  preparation  with  dilution  into  PBS  and  an  oligomer 
preparation with dilution into cold PBS + 0.05% SDS [52]. Stine et al. also examined the effect of 
temperature and ionic strength on the oligomeric band pattern obtained after incubation of 100  M 
Aβ1-42  for  24 h.  An  increase  in  temperature  from  4  to  37  °C  resulted  in  a  decreased  intensity  of 
monomer and trimer bands and an increased intensity of the tetramer band. In addition, a smear for 
oligomeric species ranging from 30 to 70 kDa appeared at 25 °C with increased intensity at 37 °C. The 
effect of ionic strength was probed using the oligomer preparation at 37 °C with incubation for 24 h in 
either 10 mM Tris (pH 7.4) or 10 mM Tris supplemented with 150 mM NaCl. Both preparations yielded 
bands for monomer, trimer, and tetramer. However, the oligomer preparation in 10 mM Tris gave an 
intense oligomer smear from 30 to 97 kDa while the preparation in 10 mM Tris supplemented with  
150 mM NaCl showed a less intense oligomer smear from 40 to 50 kDa. Ying et al. have also utilized 
the  same  Aβ1-42  oligomer  preparation  as  Stine  et  al.  but  employed  for  detection  the  monoclonal 
antibody A8, which is specific for oligomers [45]. A smear for oligomeric species ranging from 16.5 to 
25 kDa was observed with antibody A8 (Figure 3, lanes 2 and 3). A poorer resolution of oligomers and 
larger species were obtained using the 6E10 antibody (Figure 3, lane 4). These results show that 6E10 
may be reacting more strongly with higher molecular weight oligomers or that these antibodies bind 
preferentially to different sizes of Aβ1-42 oligomers. While Western blotting does facilitate detection of 
intermediate Aβ oligomers, the presence of a gel smear in many of the studies outlined above indicates 
that this technique does not allow quantification of individual sizes of oligomers in this range. 
 Int. J. Mol. Sci. 2012, 13  3045 
 
Figure 3. Aβ1-42 oligomers obtained upon incubation at 4 °C for 24 h. A 5 mM Aβ1-42 
sample was prepared in DMSO and diluted to 100 µM in Ham’s F12 medium without 
phenol  red.  Oligomer  mixture  was  separated  by  15%  SDS-PAGE,  transferred  to 
nitrocellulose membranes, and probed with monoclonal antibody A8 (Lanes 2 and 3) or 
6E10 (Lane 4). Sample in Lane 2 was heat denatured prior to analysis, while sample in 
Lane  3  was  untreated.  Reprinted  from  [45]  with  permission.  The  publisher  for  this 
copyrighted material is Mary Ann Liebert, Inc. publishers. 
 
2.3. SDS-PAGE in Combination with Other Techniques 
SDS-PAGE  has  been  used  in  combination  with  oligomer  stabilization  techniques.  One  such 
technique that has been applied by Bitan et al. is Photoinduced Cross-Linking of Unmodified Proteins 
(PICUP)  [62].  PICUP  was  developed  in  the  Kodadek  laboratory  in  1999  to  study  proteins  that 
naturally form stable homo- or heterooligomers [63]. This technique provides a snapshot of different 
oligomer species present in solution at different times. Protein cross-linking is achieved via the visible 
light excitation of a tris(2,2'-bipyridyl)dichlororuthenium(II) complex which, through a series of steps, 
leads  to  the  generation  of  a  free  protein  radical  [62,64].  This  radical  can  attack  an  unmodified 
neighboring protein and form a covalent bond. Therefore, PICUP can be used to covalently freeze 
components of the sample, and these components may be separated and analyzed via techniques such 
as SDS-PAGE [62]. 
Bitan et al. have applied PICUP to compare low molecular weight fractions of Aβ1-40 and Aβ1-42, 
where these fractions were isolated by SEC and analyzed via SDS-PAGE [65]. Aβ1-40 exhibited bands 
for monomer, dimer, trimer, and tetramer with more faint bands for pentamer and heptamer (Figure 4, 
lane 2). A distinctly different low molecular weight Aβ1-42 oligomer size distribution, consisting of 
three groups of oligomers of varying band intensity, was obtained (Figure 4, lane 4). This pattern led to 
the  conclusion  that  the  initial  phase  of  Aβ1-42  oligomerization  involves  the  formation  of 
pentamer/hexamer  subunits  which  then  associate  to  form  larger  oligomers  and  intermediates,  or Int. J. Mol. Sci. 2012, 13  3046 
 
protofibrils [65]. Furthermore, they found that for Aβ1-40, monomer through tetramer were preexisting 
species in solution, while pentamer through heptamer were formed via a diffusion-dependent reaction 
of these preexisting species with free monomer. Their results verified that PICUP was capable of 
“freezing” preexisting oligomers but was also capturing oligomeric species which were not formed 
under typical aggregation conditions, thereby misrepresenting the true Aβ1-40 oligomerization pattern. 
In addition, this study examined samples that were not cross-linked via PICUP before separation by 
SDS-PAGE. A single monomer band was obtained for Aβ1-40 (Figure 4, lane 1), while Aβ1-42 exhibited 
only  bands  for  monomer  and  trimer  (Figure  4,  lane  3).  These  results  indicate  that  oligomers  not 
stabilized via PICUP were underestimated by SDS-PAGE results. 
Figure 4. SDS-PAGE analysis of non-cross-linked (lanes 1 and 3) and cross-linked (lanes 
2 and 4) Aβ1-40 and Aβ1-42. Densitometric intensity profiles of lanes 2 and 4 are shown on 
the right and left sides of the gel, respectively. Molecular weight standards are shown on 
the left in kDa. Adapted from [62] with permission. Copyright (2003) National Academy 
of Sciences, U.S.A. 
 
SDS-PAGE has also been combined with SEC to investigate Aβ aggregation [25,66,67]. A study by 
Podlisny et al. used SDS-PAGE and SEC to observe the aggregation process of Aβ1-40 secreted from 
CHO cells [66]. Soluble, SDS-stable aggregates of 6–25 kDa, were detected during the first 4.5 h of 
incubation at 37 °C via added radioiodinated synthetic Aβ1-40 at low nanomolar concentrations. These 
6–25 kDa Aβ oligomers represented ~18% of the total Aβ signal via SDS-PAGE and ~31% of the total 
Aβ signal via SEC. This low conservation of the Aβ gel signal over time to oligomeric species again 
indicates that SDS-PAGE underestimates the amount of aggregation. A study by Walsh et al. compared 
size estimations via SEC to those obtained by analyzing these SEC fractions by SDS-PAGE [25]. Aβ1-40 
and Aβ1-42 were dissolved in Tris-HCl (pH 7.4) and incubated for 48 and 6 h, respectively, at room 
temperature. SEC fractions corresponding to Aβ1-40 dimers, protofibrils, and fibrils produced a single 
band at ~4 kDa on SDS-PAGE. The SEC fraction for Aβ1-42 dimers produced a single SDS-PAGE 
band at ~4 kDa, while the SEC fraction for Aβ1-42 protofibrils and fibrils produced a ladder of sizes 
ranging only from monomer to pentamer. These results suggest that SDS-PAGE may not accurately 
detect Aβ aggregate sizes produced throughout aggregation. Int. J. Mol. Sci. 2012, 13  3047 
 
2.4. Summary of SDS-Based Methods 
As a standalone technique, SDS-PAGE is able to detect Aβ1-42 species ranging from monomer to 
tetramer. Native-PAGE has been used to separate Aβ1-40 species ranging from monomer to pentamer. 
However, for higher order oligomers, these techniques only give a range of sizes that appear as a 
smear on the gel. SDS-PAGE is often coupled with other techniques such as Western blotting and 
PICUP to enhance the resolution of Aβ sizes. By coupling SDS-PAGE to these techniques, a better 
resolution of Aβ1-40 species which appear as individual gel bands corresponding to monomer, dimer, 
trimer, and tetramer and Aβ1-42 species which appear as individual gel bands corresponding to monomer, 
trimer, tetramer,  and hexamer has  been obtained. However, the resolution of intermediate sized Aβ 
oligomers ranging from 30–70 kDa by PAGE remains a significant challenge. The addition of SDS 
may also lead to complications including the acceleration of aggregation and the increased instability 
of oligomers, thereby misrepresenting the distribution of Aβ oligomeric species. 
2.5. Capillary and Microfluidic Capillary Electrophoresis 
Capillary  electrophoresis  (CE)  is  another  electrophoretic  technique  employed  for  size  based 
separations of Aβ. CE offers a fast and highly efficient separation of molecules with a broad range of 
properties thereby making it well suited for the separation of different sizes of protein aggregates [68]. 
CE separates molecules based on electrophoretic mobility, which results from differences in charge, 
shape, and/or size, and may be used either with or without SDS. Thus, CE allows a highly efficient 
separation and resolution of native forms of Aβ species, thereby overcoming the problem of gel smearing 
in many SDS  and native-PAGE  gel separations. CE detection typically  uses  either ultraviolet (UV) 
absorbance or laser induced fluorescence (LIF) to detect proteins. UV can detect proteins without any 
additional labeling, but typically has a lower sensitivity than LIF. LIF usually requires labeling of the 
molecules, but is highly sensitive, with previous reports of CE-LIF detection of double-stranded DNA 
down to the pg/ L range [69,70]. The ability to detect biomolecules at these low concentrations is 
necessary for the analysis of physiologically relevant protein concentrations. 
CE  with  UV  detection  has  been  utilized  by  various  researchers  to  detect  Aβ  species  from  
monomers to large aggregates. Verpillot et al. used CE-UV to separate monomeric Aβ ranging in size 
from 37–42 residues and differing in length by a single residue, however they did not examine Aβ 
aggregation [71]. A study by Sabella et al. applied CE-UV with an SDS rinse for the detection of Aβ1-40 
and Aβ1-42 oligomers formed in PBS (pH 7.4) at room temperature [72]. At 0 h, peaks for Aβ1-42 
oligomers in a size range from monomers to undecamers (~50 kDa)/dodecamers (~54 kDa) and larger 
aggregates were obtained (Figure 5, t0). A similar peak pattern was obtained over an incubation time 
period of 24 h with an increase in intensity of the higher molecular mass (>50 kDa) oligomer peak 
(Figure 5, t = 1440 min). However, resolution of individual species, especially in the larger aggregate 
peak, was not achieved. Compared to Aβ1-42, the peaks for Aβ1-40 were better resolved, but a drastically 
different  peak  pattern  was  observed.  At  0  h,  three  peaks  ranging  in  size  from  3  to  30  kDa  were 
obtained. A decrease in the intensity  of the 10 to 30 kDa peak was observed over  an incubation  
period of 24 h with the disappearance of all peaks after 48 h. This result shows that CE-UV is capable 
of  detecting  small  Aβ1-40  species  and  intermediate  oligomeric  Aβ1-42  species.  In  addition,  the  CE Int. J. Mol. Sci. 2012, 13  3048 
 
electrophoretic profiles of Aβ1-40 and Aβ1-42 differ significantly, supporting observations by PAGE that 
these two proteins differ in their early stages of aggregation. 
Figure 5. Electropherograms for Aβ1-42 species formed in room temperature PBS (pH 7.4) 
at different elapsed aggregation times from t0. CE was performed with 50 mbar pressure 
injection for 8 s with separation at 16 kV. Molecular weights corresponding to each peak 
were determined using Microcon centrifugal filter units with molecular weight cutoffs of 3, 
10,  30,  and  50  kDa.  Peaks  with  migration  times  of  5–10  min  represent  monomers  to 
undecamers/dodecamers  (3–50  kDa)  and  peaks  with  migration  times  of  10–15  min 
represent larger aggregates (>50 kDa). Reprinted from [72] published by John Wiley and 
Sons, © 2004 WILEY-VCH Verlag GmbH & Co. KGaA. 
 
Picou et al. also observed substantial differences in the CE-UV electrophoretic profiles of Aβ1-40 
and Aβ1-42 [73]. Two different preparations typically employed to form Aβ monomer or fibril were 
used. The Aβ1-40 monomer preparation yielded a single monomer peak with a molecular weight of  
4.3  kDa.  In  contrast  to  Aβ1-40,  the  Aβ1-42  monomer  preparation  gave  peaks  for  both  monomer  
and fibrillar species. A peak pattern similar to the Aβ1-42 monomer preparation was also obtained for 
the Aβ1-40 fibril preparation. The Aβ1-42 fibril preparation produced multiple aggregate peaks and no 
monomer  peak.  Although  this  study  was  able  to  separate  Aβ  monomer  from  mature  fibrils,  the 
detection of oligomeric Aβ species was not achieved. 
LIF detection has also been utilized as a more sensitive means of identifying lower concentrations 
of  Aβ  aggregate  species  separated  using  CE.  A  study  of  the  aggregation  patterns  of  Aβ1-42  using  
CE-LIF was conducted by Kato et al. [74]. The fluorescent dye thioflavin T (ThT) was used to detect 
two different Aβ1-42 aggregate sizes with a 5 min analysis time [74]. In addition, this study examined 
the effect of seeding a freshly prepared Aβ1-42 sample with a fibrillar Aβ1-42 seed. For samples without 
a seed, a broad peak was observed with CE-LIF as opposed to seeded samples that contained both a 
sharp and broad peak, although no specific sizes were determined. Int. J. Mol. Sci. 2012, 13  3049 
 
In  addition  to  CE-LIF,  microfluidic  capillary  electrophoresis  (MCE)  has  been  used  to  study  
Aβ. MCE is similar to CE except operates on a much smaller scale. The advantages of MCE over 
conventional  electrophoresis  methods  include  low  sample  consumption  and  a  strong  potential  for 
automation and integration [75,76]. MCE has been utilized to study Aβ monomeric species. A study by 
Mohamadi et al. utilized MCE-LIF for the separation of five Aβ isoforms (Aβ1-37, Aβ1-38, Aβ1-39, Aβ1-40, 
and Aβ1-42) [77]. However, MCE has yet to be applied for the study of Aβ oligomers. 
CE as a technique for the detection of Aβ species formed throughout aggregation is still in its early 
stages. CE-UV has been utilized to detect small Aβ1-40 species ranging from 3–30 kDa as well as to 
separate Aβ1-40 monomer from fibrillar species. Aβ1-42 species ranging from 3–50 kDa and >50 kDa 
have been detected using CE-UV. In addition, the separation of Aβ1-42 monomer from fibrillar species 
has been achieved using CE-UV, and the separation of two different Aβ1-42 fibrils has been accomplished 
with CE-LIF. The development of MCE has prompted researchers to apply this technique to the study of 
Aβ, with initial investigations demonstrating the separation of five Aβ isoforms differing in length by a 
single residue. The ability of CE to detect sizes from monomers to fibrils offers the potential to monitor 
the amyloid aggregation process over time, and the use of LIF provides the potential for examining 
physiologically  relevant  concentrations.  However,  further  improvements  to  this  technique  must  be 
made in order to enhance the resolution of intermediate sized Aβ species. 
3. Spectroscopic Techniques for the Quantification of Aβ Oligomer Sizes 
3.1. Mass Spectrometry 
Mass spectrometry (MS) is a widely used technique for the detection of monomeric and oligomeric 
Aβ. In MS, the sample undergoes vaporization, and components are ionized by impacting them with an 
electron beam. Ions are separated by their mass-to-charge ratio using electromagnetic fields, and the ion 
signal is processed into a mass spectrum characteristic of the analyte. MS uses a variety of ionization 
sources depending on the sample state. For vapor samples, the most common source used to generate 
gas-phase ions is a radioactive ionization (RI) source [78,79]. However, other ion sources such as corona 
discharge ionization (CDI) [80,81], photoionization (PI) [80,82], and secondary electrospray ionization 
(SESI) [83–86] have been used as well. The most commonly used ionization source for liquid samples 
is  electrospray  ionization  (ESI)  [83–86],  and  for  solid  samples  matrix  assisted  laser  desorption 
ionization (MALDI) [87–90] and laser desorption ionization (LDI) [91–93] are widely used ionization 
sources. In addition, there are various types of mass analyzers that process the ion signal into a mass 
spectrum. These include time-of-flight, quadrupole, ion trap, Fourier transform ion cyclotron, magnetic 
sector,  and  tandem  instruments  as  recently  reviewed  by  Kanu  et  al. [94].  The  most  common  MS 
techniques used for protein analyses are MALDI-MS and ESI-MS. 
3.2 Matrix-Assisted Laser-Desorption Ionization (MALDI)-MS 
MALDI-MS may be combined with other separation techniques such as SDS-PAGE to provide 
more quantitative size estimates. Iurascu et al. utilized SDS-PAGE in combination with MALDI-MS 
to analyze a solution of Aβ1-40 solubilized in fibril growth buffer at pH 7.5 for 5 days at 37 °C [48]. 
MALDI-MS indicated that the soluble fraction contained two different ion mobilities, indicative of Int. J. Mol. Sci. 2012, 13  3050 
 
oligomerization. Parallel analysis using SDS-PAGE and Tris-tricine PAGE revealed the presence of 
oligomeric Aβ1-40 of ~20 kDa (pentamer). A study by Maji et al. subjected wild-type and tyrosine 
substituted Aβ1-40 and Aβ1-42 to PICUP and quantified the resulting aggregate sizes via MALDI-MS 
and  SDS-PAGE  [95].  SDS-PAGE  yielded  wild-type  Aβ1-40  bands  for  monomer  through  hexamer. 
However, MALDI-MS was only able to attain masses for the monomer through tetramer bands, while 
masses  for  the  pentamer  and  hexamer  bands  could  not  be  measured.  This  inconsistency  could  be 
attributed to the presence of very small quantities of pentamer and hexamer. Alternatively, these species 
may not be desorbed from the MALDI matrix as readily as smaller oligomers. In addition, MALDI-MS 
spectra of tyrosine substituted Aβ1-42 oligomers were not obtained, suggesting that either these oligomers 
could  not  be  incorporated  into  the  MALDI  matrix  due  to  their  exceptional  hydrophobicity  or  their 
covalent or weak noncovalent interactions were disrupted by the desorption/ionization process. These 
results show that although MALDI-MS may be used to quantify Aβ oligomers, this technique does  
have drawbacks including limited matrix interactions as well as the inability to distinguish molecules 
with overlapping charge-to-mass ratios, expense, and labor intensive analyses [96,97]. In addition, 
since  MALDI  is  typically  coupled  with  a  pre-separation  step  such  as  SDS-PAGE,  its  detection 
capabilities may vary depending on the pre-separation technique used. 
3.3. Electrospray Ionization (ESI)-MS 
ESI-MS has been used to analyze liquid Aβ samples. Palmblad et al. have utilized ESI-MS to study 
the effect of Met-35 oxidation on the formation of Aβ1-40 oligomers [98]. They found that freshly 
dissolved Aβ1-40 and Aβ1-40Met35(O) both exhibited monomers and dimers (Figure 6, panels a and b). 
In  addition,  Aβ1-40  and  Aβ1-40Met35(O)  incubated  for  41  min  exhibited  similar  monomer  and  
dimer signals (Figure 6, panels e and f). In contrast, trimers and tetramers were detected for freshly 
dissolved Aβ1-40 (Figure 6, panel c) whereas these species were not detectable for freshly dissolved 
Aβ1-40Met35(O) (Figure 6, panel d). However, after >95 min of incubation, Aβ1-40 and Aβ1-40Met35(O) 
exhibited similar trimer and tetramer signals (Figure 6, panels g and h). These results suggest that  
Met-35 oxidation slows a conformational change that may be necessary for early formation of Aβ1-40 
trimers. Although ESI-MS can be used as a way to freeze protein oligomers in time, complications 
arise when a protein could simultaneously populate a number of states with the same mass-to-charge 
ratio [97]. This complication makes it difficult to quantify different size oligomers that have the same 
mass-to-charge ratio. 
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Figure 6. ESI-Mass spectra of 4.0 µM freshly dissolved Aβ1-40 (a and c), freshly dissolved 
Aβ1-40Met35(O) (b and d), Aβ1-40 and Aβ1-40Met35(O) incubated for 41 min (e and f), and 
Aβ1-40 and Aβ1-40Met35(O) incubated for >95 min (g and h). Aβ1-40 samples were dissolved 
in H2O and Aβ1-40Met35(O) samples were dissolved in H2O and 2.7% H2O2. Reprinted 
with permission from [98]. Copyright (2002) The American Society for Biochemistry and 
Molecular Biology. 
 
3.4. Ion Mobility (IM)-MS 
IM-MS  is  capable  of  separating  ions  by  both  their  shape  and  charge,  which  has  rendered  it  a 
successful  technique  for  the  separation  of  conformers  of  various  shapes  arising  from  a  single 
protein [94,99–101].  Ions  are  separated  in  time  according  to  their  cross  sections  by  passing  them 
through a drift cell containing helium gas under the influence of a weak electric field [102]. The  
flight times are combined with the drift times to yield the mass-to-charge IM distributions for all ions 
in the sample. The ability of IM-MS to separate species that differ in shape or size but have the  
same mass-to-charge ratio has made this technique a powerful tool for analyses of the early stages of 
Aβ oligomerization. Int. J. Mol. Sci. 2012, 13  3052 
 
Various research groups have utilized IM-MS to gain a better understanding of the early events  
of Aβ aggregation. Aβ1-40 conformational states in freshly dissolved and aggregated solutions have 
been studied by Iurascu et al. [48]. Two different conformational states were obtained for freshly 
dissolved Aβ1-40 and the soluble fraction obtained by Aβ1-40 incubation for 5 days at 37 °C and pH 7.5. 
Bernstein et al. used IM-MS to study the aggregation of Aβ1-42 versus Aβ1-42 with a Phe19→Pro19 
substitution [103]. Monomers and large oligomers were produced by unfiltered Aβ1-42, while protein 
passed through a 10,000 amu filter yielded monomer, dimer, tetramer, hexamer, and an aggregate of 
two hexamers. In contrast, the Pro19 alloform produced monomer, dimer, trimer, and tetramer but no 
large  oligomers.  In  a  more  recent  study  by  Bernstein  et  al.,  a  mechanism  for  Aβ1-40  and  Aβ1-42 
oligomerization and eventually fibril formation was postulated [104]. Using IM-MS, this group was 
able to determine the shape and size of Aβ1-40 and Aβ1-42 oligomers. Aβ1-40 oligomerization proceeded 
via the formation of dimer and tetramer followed by the very slow formation of fibrils containing a  
β-sheet structure. In contrast, Aβ1-42 proceeded via the formation of dimer, tetramer, and a hexameric 
paranucleus  followed  either  by  the  formation  of  dodecameric  species  or  the  slow  conversion  into 
fibrils containing a β-sheet structure. Representative IM-MS data obtained by Berstein et al. for Aβ1-42 
and Aβ1-40 are shown in Figure 7. Similar findings about the early oligomerization behavior of Aβ1-40 
and Aβ1-42 were obtained by Murray et al. using IM-MS [102]. In addition, these researchers found 
that in an equimolar mixture of Aβ1-40 and Aβ1-42, Aβ1-40 inhibited the formation of higher molecular 
weight oligomers by Aβ1-42. This result suggests that Aβ1-40 could sequester Aβ1-42 into stable tetramers 
and prevent the further oligomerization of Aβ1-42 into dodecameric species. 
Figure 7. IM-MS arrival time distributions for (a) 30 µM Aβ1-42 in 49.5% H2O, 49.5% 
acetonitrile,  and  1%  NH4OH  and  (b)  30  µM  Aβ1-40  in  ammonium  acetate  (pH  7.4).  
D = dimer, Te = tetramer, H = hexamer, Do = dodecamer with a z/n = −5/2. Figure 7a 
adapted  with  permission  from  [103].  Copyright  (2005)  American  Chemical  Society.  
Figure 7b adapted by permission from Macmillan Publishers Ltd.: Nature Chemistry [104], 
copyright (2009). 
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3.5. Fluorescence Correlation Spectroscopy 
Fluorescence correlation spectroscopy (FCS) has also been utilized to gain information about the 
size of Aβ species formed throughout aggregation [24,105–107]. FCS was originally developed by 
Eigen and Rigler in the early 1990s [108]. In FCS, unlabeled protein is combined with fluorescently 
labeled  protein  and,  at  various  times  throughout  aggregation,  the  fluorescent  dye  is  excited  by  a 
sharply focused laser beam. The emitted fluorescence of a small number of molecules in solution is 
observed.  The  fluorescence  intensity  fluctuates  due  to  Brownian  motion  of  the  particles,  and  an 
intensity correlation function can be used to determine the average number and average diffusion time 
(i.e., molecular size) of molecules. Advantages of FCS include high sensitivity (nM range and below), 
ability to examine a wide range of molecular sizes (i.e., monomer, oligomer, fibrils) [109], fast analysis 
times [109], and small sample volumes (femtoliter) [110]. In addition, no pre-separation step is required 
for the determination of particle radius via FCS. However, assumptions must be made about the kinetics 
of the aggregation process as well as molecular shape in order to determine molecular weight. 
Various researchers have employed FCS to monitor Aβ aggregation. A study by Matsumura et al. 
utilized  FCS  to  monitor  the  aggregation  of  Aβ1-40  and  Aβ1-42  and  observed  distinct  aggregation 
pathways, dependent upon incubation conditions, that resulted in the formation of either oligomeric 
species or fibrils [24]. Two different site-specific labels at either the N-terminus or Lys
16 were used to 
monitor aggregation. One pathway involved the formation of 10–15 nm spherical Aβ1-42 assemblies of 
~330 kDa, termed amylospheroids (ASPDs), appearing after 5 h of gentle agitation of a 50 µM Aβ1-42 
solution in F12 buffer at 4 °C. These ASPDs were formed from Aβ species of ~12.7 kDa initially 
present in solution. In addition, the aggregation pathways were similar for the N-terminus and Lys
16 
site-specific labels. An alternative pathway involved fibril formation from 100 µM Aβ1-40 solutions in 
Dulbecco’s PBS (pH 3.5) with gentle agitation at 4 °C. This pathway began with dimer formation at  
0 h, followed by the formation of intermediate sized species of 15–40 nm after 2–9 h. Eventually, 
larger molecular weight fibrils (14,000 kDa) were formed after 24 h using Aβ labeled site-specifically at 
Lys
16. However, much larger aggregates (120,000 and 3,900,000,000 kDa) were formed after 24 h using 
Aβ labeled site-specifically at the N-terminus. It was thus postulated that the Lys
16 fluorescent probe 
interfered with aggregation into larger fibrils. By employing oligomer formation conditions, Cizas et al. 
used  FCS  to  observe  much  smaller  Aβ1-42  oligomers  [105].  They  dissolved  Aβ1-42  in  HFIP  with 
subsequent dilution into de-ionized water and incubation at 20 °C with or without agitation (500 rpm) 
for 24 h. The average radius observed for unagitated samples was ~3.4 nm while the radius for agitated 
samples was ~8 nm. Garai et al. have applied FCS to monitor the Aβ1-40 aggregation process when 
monomer is initially the predominant species present in solution (Figure 8, time = 0.05 h) [107]. After 
1 h, intermediate aggregates of 20–100 nm formed and grew to sizes >1000 nm after 24 h (Figure 8, 
time = 2–24 h). These Aβ1-40 intermediate sizes are larger than those observed by Mastmura et al.  
and could be due to different sample preparations or the presence of different Aβ species at 0 h.  
These studies again show that although Aβ1-40 and Aβ1-42 differ by only two amino acid residues, the 
aggregates formed are considerably different. 
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Figure  8.  Size  distributions  obtained  via  FCS  for  Aβ1-40  dissolved  in  2.8  mM  NaOH, 
diluted to 10 µM in HEPES (pH 7.4), and incubated at room temperature. Sample taken at 
~3  min  shows  predominantly  monomeric  species  with  the  formation  of  intermediate 
aggregates of 20–100 nm after 1 h and further growth into larger aggregates >1000 nm 
after  24  h.  Adapted  with  permission  from  [107].  Copyright  (2008),  American  Institute  
of Physics. 
 
3.6. Summary of Spectroscopic Methods 
MS  is  capable  of  detecting  low  oligomer  concentrations  but  is  expensive  and  has  difficulty 
separating species with identical mass-to-charge ratios such as Aβ aggregates [96,97]. To address this 
problem, MS is often coupled with an upstream separation technique such as SDS-PAGE [48,95]. In 
addition, IM-MS has been utilized for the separation of different sizes and conformations of Aβ1-40 and 
Aβ1-42 with promising results for small oligomers. However, the addition of a step such as IM also 
increases  the  time  needed  for  analysis  and  therefore  decreases  the  chances  of  detecting  transient 
species. Consistent results for Aβ1-40 and Aβ1-42 oligomer sizes formed during the earliest events of 
aggregation have been obtained using MS techniques. However, the detection of larger Aβ1-40 and Aβ1-42 
oligomeric species ranging from ~32–~100 kDa has not been achieved using MS. FCS does not require 
a pre-separation step to determine the particle radius of species in a sample. This technique has been 
successfully applied for the detection of small and intermediate sized Aβ oligomers as well as large Aβ 
fibrils. However, FCS yields average values of particle radius for a population of aggregates and not 
individual particle sizes or their distributions. 
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4. Additional Techniques Utilized for Aβ Aggregate Size Determinations 
4.1. Light Scattering Techniques 
Light scattering techniques have been used to measure Aβ aggregate sizes. Classical, or multi-angle, 
light scattering (MALS) employs a well collimated, single frequency light beam to illuminate a sample 
of  macromolecules  [111].  When  incident  light  interacts  with  the  macromolecules  in  solution,  an 
oscillating dipole is induced and the light is re-radiated, or scattered [112]. Aggregated structures 
induce coherent scattering, and as a result the intensity of scattered light is dependent upon molar mass. 
Furthermore,  destructive  and  constructive  scattering  that  result  from  the  independent  scattering  of 
individual molecular elements can give rise to an angular dependence of the scattered light, which is a 
function of the size of the molecule. Thus, the intensity of the scattered light is measured as a function 
of scattering angle, often referred to as Rayleigh scattering, to yield the molar mass and root mean 
square (rms) radius of the macromolecules [112]. MALS is ideal for characterizing larger assemblies 
(>10 nm). In contrast, for analyses in which smaller molecules are present in solution, dynamic light 
scattering (DLS), also known as quasi-elastic light scattering (QELS), is used. DLS employs a fast 
photon counter to measure time dependent fluctuations in scattered light at a single angle (usually 90°), 
which are related to the rate of diffusion of the macromolecules [112,113]. Measurement of diffusion 
rates allows calculation of the hydrodynamic radius (RH) of macromolecules using the Stokes-Einstein 
equation [113]. When used as standalone techniques, MALS yields the weight-averaged molar mass 
for all molecules in solution. While DLS can distinguish populations that differ in size by a factor of 
five or more, individual peaks exhibit a high degree of polydispersity. Therefore, it is often necessary 
to utilize a pre-separation step in conjunction with light scattering to obtain an accurate estimate of the 
relative amounts of individual aggregates present in solution. In addition, the exponential dependence 
of scattering on aggregate size prohibits the detection of low quantities of small aggregates in the 
presence of larger species. 
Various  researchers  have  utilized  MALS  and/or  DLS  to  characterize  Aβ  assemblies  formed 
throughout  aggregation  [114–117].  Carrotta  et  al.  utilized  both  MALS  and  DLS  to  monitor  the 
aggregation of a 185 µM Aβ1-40 sample at pH 3.1 and 37 °C [117]. DLS was used to characterize 
aggregate sizes formed during the early stages of aggregation up to ~38 h, as shown in Figure 9. After  
5 min (Figure 9a), an average RH of 7 nm was obtained. The size distribution became more polydisperse 
over time and ranged from 10–52 nm after 37 h (Figure 9f). However, only average size distributions 
could be obtained and no information was reported about the concentrations of each aggregate species 
(i.e., monomer, dimer, etc.). Larger aggregates (hundreds of microns) were formed after 2 weeks as 
detected by MALS. 
Similar to these findings, Lomakin et al. observed using DLS the initial formation of a spherocylindrical 
micelle with average RH of 7 nm immediately following dissolution of Aβ1-40 at pH 2 [115]. In addition, 
they reported two different kinetic patterns for aggregation of Aβ1-40 prepared at a concentration either 
above or below the critical micelle concentration (CMC) of 100 µM [114] Complimentary DLS and 
MALS studies by Murphy and Pallitto also demonstrated an effect of Aβ concentration upon aggregate 
formation  [118].  They  demonstrated  that  dilution  of  Aβ1-40  from  urea  into  PBS  yielded  larger 
aggregates at lower protein concentrations, while the increase in RH for aggregates was proportional to Int. J. Mol. Sci. 2012, 13  3056 
 
the  protein  concentration.  In  addition,  MALS  data  indicated  that  the  linear  density  of  aggregates 
increased  with  protein  concentration.  Thunecke  et  al.  have  utilized  MALS  and  DLS  to  study  the 
aggregation of Aβ1-40 and Aβ1-42 in acetonitrile-water mixtures [116]. At the onset of aggregation, Aβ1-42 
was present as a 2 nm oligomer and rapidly formed fibrils with a length <50 nm within 4.5 h. In 
contrast, Aβ1-40 initially exhibited large aggregates that grew 70 times slower than aggregates of Aβ1-42. 
However, the presence of these large aggregates may preclude observation of a separate population of 
oligomers. These findings highlight differences in the dissolution and aggregation of Aβ1-40 and Aβ1-42. 
Figure 9. Time evolution of RH for a 185 µM Aβ1-40 sample incubated at pH 3.1 and 37 °C. 
Distributions were determined using a constrained regularization method. Reprinted with 
permission  from  [117].  Copyright  (2005)  The  American  Society  for  Biochemistry  and 
Molecular Biology. 
 
4.2. Light Scattering in Combination with Other Techniques 
Because light scattering techniques provide information about the weight-average molar mass and 
radius for all molecules in solution, they are often coupled with a pre-separation technique such as 
asymmetric field flow fractionation (AFFF) [119] or SEC [25,120,121] to better characterize individual 
Aβ oligomeric species. A study by Nichols et al. utilized MALS with SEC as well as DLS to characterize 
Aβ1-40 protofibrils following growth by monomer elongation or lateral association [120]. They found  
that protofibrils isolated by SEC exhibited an average RH of 51 nm and molecular weight, determined via Int. J. Mol. Sci. 2012, 13  3057 
 
MALS of 30,000 kDa. Protofibrils that had grown by monomer deposition had an average RH of 143 
nm and molecular weight of 57,000 kDa, while protofibrils that had grown by lateral association had 
an average RH of 104 nm and molecular weight of 86,000 kDa. Furthermore, SEC-MALS revealed that 
the mass per unit length of protofibrils was unchanged during elongation, but was increased following 
association.  The  temporal  change  in  size  of  Aβ1-40  protofibrils  isolated  by  SEC  has  also  been 
monitored via DLS by Walsh et al. [121]. The initial average RH for protofibrils isolated by SEC was 
~27.8 nm, and protofibril size grew to 80.6 nm over a period of 9 days when 17 µM Aβ1-40 in Tris-HCl 
(pH 7.4) containing 0.04% w/v sodium azide was incubated at room temperature. 
AFFF is another technique that has been coupled with light scattering to estimate the molecular 
weight of individual Aβ aggregates. AFFF exploits the parabolic flow profile created by the laminar 
flow  of  a  sample  through  a  thin,  parallel  plate  flow  channel,  where  the  lower  surface  is  solvent 
permeable [122]. A perpendicular force applied to the laminar flow stream drives molecules towards 
the permeable boundary layer of the channel [123]. Because Brownian motion of the particles creates a 
counteracting force, smaller particles localize higher in the channel leading to separation of different 
molecular sizes, with smaller molecules eluting first [122]. Rambaldi et al. utilized AFFF-MALS to 
monitor the aggregation of Aβ1-42 in PBS (pH 7.4) at room temperature over 24 h [119]. At 0 h, two 
major peaks were obtained corresponding to molecular weights of ~60 kDa and ~1000–100,000 kDa. 
In addition, the retention time of the ~60 kDa species decreased between 0 and 4 h, corresponding to 
an increase in aggregate size of 6.5–4.7 nm. The intensity of the two peaks also decreased over 24 h, 
possibly due to irreversible adsorption of the sample to the permeable surface. Although AFFF-MALS 
has several advantages, including gentle, rapid, and non-destructive separation, improvements to the 
ultrafiltration  membrane  are  critical  to  enhance  analysis  capabilities.  In  addition,  the  smallest 
molecular weight cutoff for membranes is 5 kDa, making detection of Aβ monomeric species difficult. 
4.3. Centrifugation 
Centrifugation has also been explored as a method for determining Aβ size. Here, sedimentation 
coefficient  (s)  values  can  be  correlated  with  molecular  weight.  Mok  and  Howlett  provide  a  nice 
overview of sedimentation velocity centrifugation in the context of Aβ analysis [124]. Ward et al. used 
density gradient centrifugation to fractionate Aβ1-40 samples incubated at pH 7.4, 35 °C for 30 min,  
18 h, or 18 days [26]. Using SDS-PAGE with Western blotting to analyze sedimented samples, they 
found that Aβ1-40 incubated for 18 h contained only small molecular weight oligomers (4–17 kDa), 
while Aβ1-40 incubated for 18 days showed the presence of a >250 kDa band as well as significant 
streaking,  indicating  other  unresolved  sizes.  Huang  et  al.  used  analytical  ultracentrifugation  to 
compare Aβ1-40 samples prepared at pH 3, 5, and 7 [125]. They determined that at pH 5 there were no 
soluble aggregate species. At pH 7, they identified small oligomers with an average molar mass of 
12.1 kDa, and at pH 3 they identified a range of aggregate sizes with an average molecular weight of  
1 MDa. Nagel-Stefer et al. also used sedimentation velocity centrifugation for the analysis of Aβ1-42 
samples after 5 days of agitation at room temperature and were able to detect “globular species” ranging 
in  size  from  ~270  kDa–3.8  MDa  as  well  as  even  larger  aggregates  [126].  Interestingly,  they  also 
compared  three  different  simulation  methods  for  determining  molecular  weight  from  sedimentation 
values and obtained molar masses that differed by approximately one order of magnitude. Int. J. Mol. Sci. 2012, 13  3058 
 
4.4. Size Exclusion Chromatography 
SEC, a chromatographic technique, separates molecules based on molecular hydrodynamic volume 
or size. Molecules too large to penetrate the pores of the column packing material elute in the void 
volume, while smaller molecules travel through the pores and elute at later times. Globular proteins  
are  often  used  as  standards  to  estimate  the  size  of  Aβ  oligomers.  However,  since  Aβ  is  a  linear, 
hydrophobic peptide, comparisons between the elution behavior of Aβ oligomers and size standards 
are difficult [127]. In addition, the sample is subjected to a several-fold dilution, which facilitates the 
dissociation of small unstable oligomers [128], thereby precluding the detection and size estimation of 
these species. 
Although SEC is typically utilized in conjunction with another technique, SEC as a standalone 
technique has been employed for the study of Aβ aggregates [129–131]. Englund et al. used SEC to 
detect low molecular weight Aβ aggregates, Aβ protofibrils, and Aβ fibrils formed using different Aβ 
sample preparations [130]. The size of low molecular weight Aβ aggregates ranged from 4–20 kDa 
(Figure 10, panel a), while Aβ protofibrils were >100 kDa (Figure 10, panel c). A more narrow size 
distribution of Aβ1-42 oligomers of 24 ± 3 kDa (pentamer–hexamer) has been obtained by Ahmed et al. 
with SEC [129]. This resolution was achieved by stabilizing Aβ1-42 oligomers at a low temperature 
(4 °C) and low salt concentration (10 mM NaCl). Zheng et al. have analyzed via SEC freshly prepared 
1 mg/mL Aβ1-40 in PBS (pH 7.4), diluted from DMSO, and achieved resolution of an Aβ1-40 trimer 
with molecular weight of 11.6–15.7 kDa [131]. The difference in sizes obtained by Ahmed et al. and 
Zheng  et  al.  most  likely  result  from  differences  in  sample  preparation.  While  these  studies  show 
promising  results  for  resolution  of  a  single  low  molecular  weight  Aβ  oligomer,  the  resolution  of 
individual intermediate Aβ oligomeric sizes formed during aggregation has not been achieved using 
SEC as a standalone technique. 
Figure  10.  HPLC-SEC  chromatograms  of  Aβ  aggregates  produced  using  sample 
preparations of 50 µM synthetic Aβ designed to optimize (a) low molecular weight Aβ1-40 
oligomers and (c) Aβ1-42 protofibrils. To ensure that insoluble fibrils were not present in 
solution, these species  were removed via centrifugation prior to analysis, and this was 
confirmed by an absence of SEC signal in (b), a fibrillar Aβ1-42 preparation. Absorbance at 
214 nm is given on the y-axis and retention time is given on the x-axis. Adapted from [130] 
published by John Wiley and Sons, © 2007 The Authors Journal Compilation © 2007 
International Society for Neurochemistry.  
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Figure 10. Cont. 
 
4.5. Summary of Additional Aβ Aggregate Size Determination Techniques 
Light scattering techniques, such as MALS and DLS, have been used to detect both small and large 
Aβ aggregates. DLS is more suitable for the detection of smaller aggregates and gives information 
about aggregate size, or RH, while MALS has been utilized for the detection of larger Aβ species, 
including fibrils, and can provide information about molar mass. MALS and DLS, however, give a 
weight-average  molar  mass  or  RH  for  all  molecules  in  solution  and  must  be  coupled  to  another 
technique in order to increase the resolution of individual sizes. SEC as a standalone technique has 
been utilized to detect low molecular weight Aβ oligomers and protofibrils, and SEC-MALS has been 
used  to  characterize  protofibrils  formed  via  different  growth  mechanisms.  However,  due  to  the 
dilutions required by SEC, small unstable oligomers are often dissociated, thereby precluding their 
analysis. AFFF-MALS does not require a pre-fractionation step and has been used to separate Aβ 
oligomers of ~60 kDa from larger species. This technique yields a gentle, non-destructive separation of 
molecules. However, further improvements to the ultrafiltration membranes must be made in order to 
reduce  adsorption  of  the  sample  to  the  membrane.  Centrifugation  has  also  been  explored  for  the 
separation of small oligomers (4–17 kDa) and larger species (>250 kDa) but requires an uncertain 
correlation of sedimentation coefficients with molar mass. Each of these techniques are suitable for the 
detection of a wide range of Aβ aggregates present throughout aggregation but present difficulties with 
respect to the resolution and quantification of individual Aβ aggregate sizes. 
5. Techniques Utilized for Aβ Oligomer Identification 
While this review focuses primarily on techniques capable of qualitatively determining the size of 
Aβ oligomers, techniques that can identify the presence of oligomers, without providing information 
about oligomer size, are also available. Although qualitative in nature, we have chosen to briefly discuss 
two of these techniques, dot blot and ELISA, as a result of their frequent use and emerging interest. 
5.1. Dot Blot 
Dot blots employ a protein captured upon a membrane as a spot, or dot. A primary antibody binds 
to the protein epitope of interest followed by the binding of a secondary antibody to facilitate detection. 
When dot blots are probed with antibodies that specifically recognize oligomeric Aβ, they can confirm 
the presence of oligomers but give no information about aggregate size. Three different Aβ antibodies, Int. J. Mol. Sci. 2012, 13  3060 
 
oligomer-specific A11 or sequence specific 4G8 and 6E10 (see Table 1 for Aβ binding epitopes), were 
employed in conjunction with a dot blot assay for detection of aggregating Aβ by Wong et al. [57]. 
Aβ1-40 was diluted to 50 µM in PBS (pH 7.4) and incubated at 37 °C. At times ranging from 0–3 days, 
a  sample  was  analyzed  via  dot  blot,  as  shown  in  Figure  11.  A11  binding  revealed  the  transient 
appearance of oligomers in uninhibited samples, while detection via 4G8 and 6E10 remained constant 
until  later  times  when  signals  decreased,  presumably  due  to  masking  of  binding  sites  following 
aggregation. Changes in these patterns in the presence of inhibitor demonstrated the ability of the 
inhibitor to prevent oligomer formation and slow the evolution of larger aggregates. Necula et al. used 
a dot blot assay to monitor the oligomerization of Aβ1-42 dissolved in 100 mM NaOH, diluted to 45 µM 
in PBS (pH 7.4), and incubated at room temperature for 10 days [132]. Similar to Wong et al., they 
probed the specificity of three different antibodies, oligomer-specific A11 and sequence specific 6E10 
and 4G8. At 0 days, 6E10 and 4G8 strongly reacted with Aβ1-42 aliquots, while A11 reacted weakly, 
indicating  that  only  monomeric  species  were  present.  A  strong  immunoreactivity  for  A11  was 
observed after 4 days and continued to increase in intensity over 10 days, similar to results obtained by 
Wong et al. Again, this was accompanied by a decrease in immunoreactivity of 6E10 and 4G8. 
Figure 11. Aβ aggregation monitored via dot blot. A 50 µM Aβ1-40 sample was incubated 
in PBS (pH 7.4) at 37 °C in the presence (+) or absence (−) 3 x Brilliant Blue G (BBG) 
inhibitor.  Samples  were  taken  on  the  indicated  days  and  spotted  on  a  nitrocellulose 
membrane. Oligomer-specific A11 antibody and Aβ-sequence specific antibodies 4G8 and 
6E10  were  used  to  detect  aggregates.  Reprinted  with  permission  from  [57].  Copyright 
(2011) American Chemical Society. 
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5.2. Enzyme-Linked Immunosorbent Assay 
ELISA is a commonly used technique for the identification of Aβ oligomers. ELISA may be used in 
a traditional or sandwich assay format. In the traditional format, protein adsorbed at a surface can be 
detected  using  a  primary  antibody  that  is  specific  for  Aβ  oligomers  (see  Table  1).  This  primary 
antibody can be directly linked to an enzyme that converts added substrate to a detectable signal (direct 
ELISA) or can be coupled with a secondary antibody containing the enzyme moiety (indirect ELISA). 
The latter format serves to enhance the assay signal. Alternatively, in the sandwich ELISA format, a 
sequence-specific capture antibody (see Table 1) adsorbed onto the surface is used to capture  Aβ 
protein, which is subsequently detected using the same sequence-specific antibody, such that only Aβ 
species containing multiple monomeric units, and therefore multiple epitopes, are detected [130,133]. 
Consequently,  this  sandwich  ELISA  will  recognize  only  aggregated  Aβ,  but  not  Aβ  monomer. 
Although ELISA can identify the presence of Aβ oligomers in a sample, this technique is not capable 
of  determining  sizes  of  these  oligomeric  species.  Therefore,  ELISA  is  most  advantageous  for  the 
detection of oligomeric Aβ within a sample containing many different proteins. 
Various researchers have utilized ELISA for the detection of Aβ oligomers [128,130,133–135]. A 
study by Englund et al. employed a sandwich ELISA with monoclonal antibody 158 for the detection 
of  low  molecular  weight  oligomeric  Aβ1-40  produced  by  dissolving  Aβ1-40  in  10  mM  NaOH  with 
dilution to 50 µM in 2 X PBS and Aβ1-42 protofibrils produced by dissolving Aβ1-42 in 10 mM NaOH 
with dilution to 443 µM in 2 X PBS and incubation overnight at 37 °C [130]. Gonzales et al. utilized a 
similar ELISA assay to detect low molecular weight Aβ1-42 formed by dissolving Aβ1-42 in HFIP with 
dilution to 200 nM in PBS (pH 7.2) and incubation at 37 °C for 24 h [133]. The size of these species 
was  confirmed  with  PAGE  to  be  tetramer  and  pentamer;  however,  the  bands  were  very  faint, 
indicating the superior sensitivity of the ELISA assay for these oligomeric species. A detection limit 
for Aβ1-40 oligomers of 80 nM was obtained in these studies. 
5.3. Summary of Aβ Oligomer Identification Techniques 
Dot blots and ELISAs have been employed to detect oligomeric Aβ assemblies. Dot blots have been 
used to observe the transient evolution of oligomers during aggregation, but provided no information 
about  Aβ  aggregate  size.  Low  molecular  weight  Aβ  oligomers  and  Aβ  protofibrils  have  been  
detected via ELISA at nanomolar concentrations. However, PAGE was required to estimate the size of 
these species. Thus, these techniques can sensitively confirm the presence of oligomers but yield no 
size information. 
6. Conclusions 
This review describes a variety of techniques, summarized in Table 2, that are currently utilized to 
determine the size or presence of Aβ aggregates, with a focus upon oligomeric species. These techniques 
have been explored for the quantitative detection of different aggregate sizes with various limitations to 
their resolution, dependence on pre-analysis procedures, sensitivity, cost, etc. Electrophoretic techniques, 
such  as  SDS-PAGE,  Western  blotting,  and  CE,  are  widely  used  for  size-based  separations  of  Aβ 
aggregates. In particular, SDS-PAGE and Western blotting are suitable for the detection of monomeric Int. J. Mol. Sci. 2012, 13  3062 
 
and  small  oligomeric  Aβ  species.  The  separation  of  larger  oligomers  via  SDS-PAGE  is  more  
difficult due to the sensitivity of these sizes to denaturing conditions, which can result in aggregate 
decomposition during analysis. The recent development of antibodies specific for Aβ oligomers has led 
to an increase in the application of Western blotting, dot blotting, and ELISA to study Aβ aggregation. 
However, the detection limits of Western and dot blotting prohibit study of physiologically relevant Aβ 
concentrations. While more sensitive, ELISA is better suited for the identification of specific analytes, 
such as Aβ oligomers, present within a mixed population but cannot distinguish individual oligomer 
sizes.  CE  with  LIF  detection  offers  a  highly  sensitive  detection  of  physiologically  relevant 
concentrations, but the application of CE to amyloid aggregation analyses is still in the early stages. 
MS  is  another  commonly  used  technique  for  Aβ  aggregate  size-based  separations.  MS  has  been 
successfully used to detect small oligomeric species (especially IM-MS) but quantitative analyses of 
aggregate size may be limited by the pre-separation step, the ability to differentiate species with highly 
similar charge-to-mass ratios, and high equipment costs. FCS, MALS, and DLS may be utilized for 
determination of Aβ aggregate size, but yield a weight-averaged molecular weight of species, thereby 
limiting the resolution of individual Aβ aggregate species. Centrifugation has been used to examine 
small oligomeric species up to large fibrils; however, selection of the method for determination  of  
molar mass from sedimentation coefficients can play an important role in size estimation. SEC may be 
coupled with these approaches or used as a standalone technique; however, SEC is complicated by 
dilution of the analyte during separation, inadequate resolution of intermediate oligomeric species, and 
limited utility of size standards. 
Table 2. Summary of techniques for the quantitative detection and/or identification of Aβ 
aggregate sizes formed throughout the aggregation process. 




SDS-PAGE  • SDS offers strong size-
based separation 
• SDS may induce non-native 
behavior and destabilize 
oligomers 




Native PAGE  • Ability to separate based 
on charge and 
hydrodynamic size 




Western Blotting  • High sensitivity and 
specificity, 
• Requires specific and 
expensive antibodies 
• Incomplete transfer of proteins 
onto membrane 
• Technically demanding 
4–16 kDa, 
16.5–25 kDa, 







• Fast, highly sensitive 
separation of proteins 
based on charge and 
hydrodynamic size 
• Low sample volume 
• Low resolution of intermediate 
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Table 2. Cont. 
Mass 
Spectrometry 
• Fast data acquisition 
• Can identify multiple 
species with different 
mass-to-charge ratios 
• Inability to distinguish 
molecules with overlapping 
mass-to-charge ratios (MALDI, 
ESI) 
• Expensive 










• High sensitivity, ability to 
look at wide range of 
sizes within a sample 
• Fast analysis time 
• Low sample volume 
• Relies on assumptions about 
shape and kinetics of protein to 
determine molecular weight 
• Yields average molecular 
weight values 





Light Scattering  • Direct measurement of 
molar mass and radius 
(MALS) 
• Simultaneous detection of 
multiple populations 
within a sample (DLS) 
• Yields weight-average molar 
mass and not size of individual 
species or their distribution 
• Exponential dependence of 
scattering on aggregate size 
>10 kDa  
(MALS) 
1 nm–1 µm  
(DLS) 
[112,116,117] 
Centrifugation  • Ability to detect a wide 
range of sizes 
(oligomers–fibrils) 
• Fast analysis time 
• Theoretical size estimate 
depends on appropriate 
assumptions in the model 
4–17 kDa, 
>250 kDa, 




• Well established 
technique 
• Leads to sample dilution which 
can dissociate unstable 
oligomers 
• Comparisons between elution 
behavior of oligomers and 
globular protein standards 









• Highly sensitive and 
specific 
• Ability to measure 
specific analytes within a 
crude preparation 
• Versatile 
• Gives information about 
presence of oligomers and not 
size 





Dot Blot  • Straight-forward, rapid 
technique 
• Gives information about 
presence of oligomers and not 
size 





Although each of the methods discussed in this review has the capability to determine Aβ aggregate 
size,  the  pathogenic  events  that  initiate  the  misfolding  of  Aβ  and  formation  of  aggregate  species 
remain elusive. Hence, there is a continued need for improvement of these techniques in order to 
realize  the  effective  detection  of  small  size  differences  in  Aβ  oligomers.  In  order  to  leverage  the Int. J. Mol. Sci. 2012, 13  3064 
 
advantages of each Aβ detection method, a combination of approaches must be utilized, allowing 
validation of findings from different techniques and a better understanding of the early events of the 
Aβ aggregation process. 
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